EFG
VRTX icon

Everhart Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Everhart Financial Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Buy
2,566
+111
+5% +$49.2K 0.08% 131
2026
Q1 		$1.1M Buy
2,455
+204
+9% +$95.1K 0.09% 151
2025
Q4 		$1.02M Buy
2,251
+163
+8% +$70.3K 0.09% 151
2025
Q3 		$818K Buy
2,088
+207
+11% +$86.5K 0.08% 178
2025
Q2 		$837K Sell
1,881
-328
-15% -$151K 0.1% 147
2025
Q1 		$1.07M Buy
2,209
+553
+33% +$258K 0.15% 100
2024
Q4 		$667K Sell
1,656
-480
-22% -$222K 0.14% 150
2024
Q3 		$993K Buy
2,136
+617
+41% +$296K 0.22% 102
2024
Q2 		$712K Buy
1,519
+214
+16% +$92.9K 0.18% 115
2024
Q1 		$546K Buy
1,305
+138
+12% +$58.3K 0.16% 137
2023
Q4 		$475K Buy
1,167
+53
+5% +$19.6K 0.17% 118
2023
Q3 		$387K Buy
1,114
+105
+10% +$36.7K 0.16% 118
2023
Q2 		$355K Buy
1,009
+84
+9% +$28.3K 0.15% 137
2023
Q1 		$291K Buy
925
+120
+15% +$36K 0.13% 142
2022
Q4 		$232K Sell
805
-338
-30% -$103K 0.12% 154
2022
Q3 		$331K Buy
1,143
+77
+7% +$22.2K 0.18% 110
2022
Q2 		$300K Buy
+1,066
New +$285K 0.18% 120

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Everhart Financial Group's VRTX Position: Q2 2026 in Review

Everhart Financial Group increased its Vertex Pharmaceuticals (VRTX) stake by 4.5% in Q2 2026, buying an estimated $49.2K and bringing the position to 2,566 shares worth $1.27M. The position accounts for 0.08% of the portfolio, ranked #131.

Everhart Financial Group first reported a position in VRTX in Q2 2022 and has held it in 17 quarters since. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Everhart Financial Group held 2,566 shares of Vertex Pharmaceuticals worth $1.27M as of Q2 2026.
  • Everhart Financial Group bought 111 Vertex Pharmaceuticals shares in Q2 2026, an estimated $49.2K.
  • Vertex Pharmaceuticals made up 0.08% of Everhart Financial Group's portfolio in Q2 2026, its #131 holding.
  • Everhart Financial Group first reported a position in Vertex Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
  • 334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Everhart Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.